(Q44729759)

5 December 2017

title

Dopamine transporter binding in Gilles de la Tourette syndrome: a [123I]FP-CIT/SPECT study (English)

1 reference

5 December 2017

0 references

1 reference

6

Lees AJ

1 reference

5 December 2017

Serra-Mestres J

1

1 reference

5 December 2017

Ring HA

2

1 reference

5 December 2017

Costa DC

3

1 reference

5 December 2017

Gacinovic S

4

1 reference

5 December 2017

Walker Z

5

1 reference

5 December 2017

Robertson MM

7

1 reference

5 December 2017

Trimble MR

8

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 February 2004

1 reference

Acta Psychiatrica Scandinavica

5 December 2017

published in

1 reference

5 December 2017

volume

109

1 reference

5 December 2017

issue

2

1 reference

5 December 2017

page(s)

140-146

1 reference

The metabolic anatomy of Tourette's syndrome

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-690X.2004.00214.X

Elevated frontal cerebral blood flow in Gilles de la Tourette syndrome: a 99Tcm-HMPAO SPECT study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-690X.2004.00214.X

Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-690X.2004.00214.X

High presynaptic dopaminergic activity in children with Tourette's disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-690X.2004.00214.X

Tourette's syndrome: [I-123]beta-CIT SPECT correlates of vocal tic severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-690X.2004.00214.X

No change in striatal dopamine re-uptake site density in psychotropic drug naive and in currently treated Tourette's disorder patients: a [(123)I]-beta-CIT SPECt-study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-690X.2004.00214.X

Striatal presynaptic monoaminergic vesicles are not increased in Tourette's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-690X.2004.00214.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-690X.2004.00214.X

Reduced basal ganglia volumes in Tourette's syndrome using three-dimensional reconstruction techniques from magnetic resonance images

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-690X.2004.00214.X

Volumetric MRI changes in basal ganglia of children with Tourette's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-690X.2004.00214.X

Neuroleptics and dopamine transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-690X.2004.00214.X

Effects of antipsychotic drugs on dopamine and serotonin contents and metabolites, dopamine and serotonin transporters, and serotonin1A receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-690X.2004.00214.X

Unaltered dopamine transporter availability in adult attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-690X.2004.00214.X

123Ibeta-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0001-690X.2004.00214.X

10.1111/J.0001-690X.2004.00214.X

21 January 2018

Identifiers

DOI

1 reference

5 December 2017

1 reference